SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lien Van De Voorde, Ruben T.H.M. Larue, Madelon Pijls, Jeroen Buijsen, Esther G.C. Troost, Maaike Berbée, Meindert Sosef, Wouter van Elmpt, Marie-Céline Schraepen, Ben Vanneste, Michel Oellers, Philippe Lambin, A qualitative synthesis of the evidence behind elective lymph node irradiation in oesophageal cancer, Radiotherapy and Oncology, 2014, 113, 2, 166

    CrossRef

  2. 2
    Qing Liu, Tao Liu, Shutao Zheng, Xiangpeng Gao, Mang Lu, Ilyar Sheyhidin, Xiaomei Lu, HMGA2 is down-regulated by microRNA let-7 and associated with epithelial–mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs, Histopathology, 2014, 65, 3
  3. 3
    Miao-Fen Chen, Ping-Tsung Chen, Ming Shian Lu, Paul Yang Lin, Wen-Cheng Chen, Kuan-Der Lee, IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus, Molecular Cancer, 2013, 12, 1, 26

    CrossRef

  4. 4
    Felice Pasini, Giovanni de Manzoni, Andrea Zanoni, Antonio Grandinetti, Carlo Capirci, Michele Pavarana, Anna Tomezzoli, Domenico Rubello, Claudio Cordiano, Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response, Cancer, 2013, 119, 5
  5. 5
    Miao-Fen Chen, Yao-Hsu Yang, Chia-Hsuan Lai, Pau-Chung Chen, Wen-Cheng Chen, Outcome of Patients with Esophageal Cancer: A Nationwide Analysis, Annals of Surgical Oncology, 2013, 20, 9, 3023

    CrossRef

  6. 6
    Xuan Xie, Shui-shen Zhang, Jing Wen, Hong Yang, Kong-jia Luo, Fu Yang, Yi Hu, Jian-hua Fu, Prognostic value of HOXB7 mRNA expression in human oesophageal squamous cell cancer, Biomarkers, 2013, 18, 4, 297

    CrossRef

  7. 7
    D. Tougeron, M. Scotté, H. Hamidou, F. Di Fiore, B. Paillot, F. Michot, P. Michel, Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: An alternative to surgery?, Journal of Surgical Oncology, 2012, 105, 8
  8. 8
    Yin-Kai Chao, Hui-Ping Liu, Ming-Ju Hsieh, Yi-Cheng Wu, Yun-Hen Liu, Chi-Hsiao Yeh, Hsien-Kun Chang, Chen-Kan Tseng, Impact of the number of lymph nodes sampled on outcome in ypT0N0 esophageal squamous cell carcinoma patients, Journal of Surgical Oncology, 2012, 106, 4
  9. 9
    W.-H. Chen, Y.-K. Chao, H.-K. Chang, C.-K. Tseng, Y.-C. Wu, Y.-H. Liu, M.-J. Hsieh, H.-P. Liu, Long-term outcomes following neoadjuvant chemoradiotherapy in patients with clinical T2N0 esophageal squamous cell carcinoma, Diseases of the Esophagus, 2012, 25, 3
  10. 10
    Manabu Emi, Jun Hihara, Yoichi Hamai, Yoshiro Aoki, Morihito Okada, Masahiro Kenjo, Yuji Murakami, Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer, Cancer Chemotherapy and Pharmacology, 2012, 69, 6, 1499

    CrossRef

  11. 11
    S.-H. Li, K.-M. Rau, H.-I. Lu, Y.-M. Wang, W.-Y. Tien, J.-L. Liang, W.-C. Lin, Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma, European Journal of Cardio-Thoracic Surgery, 2012, 42, 6, 958

    CrossRef

  12. 12
    Miao-Fen Chen, Ming-Shian Lu, Ping-Tsung Chen, Wen-Cheng Chen, Paul-Yang Lin, Kuan-Der Lee, Role of interleukin 1 beta in esophageal squamous cell carcinoma, Journal of Molecular Medicine, 2012, 90, 1, 89

    CrossRef

  13. 13
    Miao-Fen Chen, Ming-Shian Lu, Paul-Yang Lin, Ping-Tsung Chen, Wen-Cheng Chen, Kuan-Der Lee, The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma, Cancer, 2012, 118, 16
  14. 14
    Yin-Kai Chao, Chi-Ju Yeh, Hsien-Kun Chang, Chen-Kan Tseng, Yin-Yi Chu, Ming-Ju Hsieh, Yi-Cheng Wu, Hui-Ping Liu, Impact of Circumferential Resection Margin Distance on Locoregional Recurrence and Survival after Chemoradiotherapy in Esophageal Squamous Cell Carcinoma, Annals of Surgical Oncology, 2011, 18, 2, 529

    CrossRef

  15. 15
    D. Tougeron, J.-P. Richer, C. Silvain, Management of esophageal adenocarcinoma, Journal of Visceral Surgery, 2011, 148, 3, e161

    CrossRef

  16. 16
    Matthew Koshy, Bruce D. Greenwald, Petr Hausner, Mark J. Krasna, Naomi Horiba, Richard J. Battafarano, Whitney Burrows, Mohan Suntharalingam, Outcomes After Trimodality Therapy for Esophageal Cancer, American Journal of Clinical Oncology, 2011, 34, 3, 259

    CrossRef

  17. 17
    D. Tougeron, J.-P. Richer, C. Silvain, Traitement des adénocarcinomes de l’œsophage, Journal de Chirurgie Viscérale, 2011, 148, 3, 184

    CrossRef

  18. 18
    Yin-Kai Chao, Yi-Cheng Wu, Yun-Hen Liu, Chen-Kan Tseng, Hsien-Kun Chang, Ming-Ju Hsieh, Yen Chu, Hui-Ping Liu, Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: Characteristics of long-term survivors after chemoradiotherapy, Journal of Surgical Oncology, 2010, 102, 2
  19. 19
    Elfriede Bollschweiler, Arnulf H Hölscher, Ralf Metzger, Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer, Future Oncology, 2010, 6, 1, 25

    CrossRef

  20. 20
    Bruce D. Minsky, Karyn Goodman, Robert Warren, Leibel and Phillips Textbook of Radiation Oncology, 2010,

    CrossRef

  21. 21
    James M. Donahue, Francis C. Nichols, Zhuo Li, David A. Schomas, Mark S. Allen, Stephen D. Cassivi, Aminah Jatoi, Robert C. Miller, Dennis A. Wigle, K. Robert Shen, Claude Deschamps, Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival, The Annals of Thoracic Surgery, 2009, 87, 2, 392

    CrossRef

  22. 22
    E. van Meerten, A. van der Gaast, H.W. Tilanus, J.W. Poley, K. Muller, H. van Dekken, Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: The rotterdam experience, Journal of Surgical Oncology, 2009, 100, 1
  23. 23
    Yin-Kai Chao, Sheng-Chieh Chan, Yun-Hen Liu, Huan-Wu Chen, Yung-Liang Wan, Hsien-Kun Chang, Kang-Hsing Fan, Hui-Ping Liu, Pretreatment T3-4 Stage is an Adverse Prognostic Factor in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response Following Preoperative Chemoradiotherapy, Annals of Surgery, 2009, 249, 3, 392

    CrossRef

  24. 24
    Yin-Kai Chao, Chi-Ju Yeh, Wen-Yu Chuang, Kang-Hsing Fan, Ming-Ju Hsieh, Yen Chu, Ann-Joy Cheng, Hui-Ping Liu, Prognostic significance of immunohistochemically detected lymph node micrometastases in pT0N0 esophageal squamous cell carcinoma, Journal of Surgical Oncology, 2009, 100, 7
  25. 25
    Björn L. D. M. Brücher, Stephen G. Swisher, Alfred Königsrainer, Derek Zieker, Jörg Hartmann, Hubert Stein, Yuko Kitagawa, Simon Law, Jaffer A. Ajani, Response to Preoperative Therapy in Upper Gastrointestinal Cancers, Annals of Surgical Oncology, 2009, 16, 4, 878

    CrossRef

  26. 26
    Silvia Gómez Senent, César Gómez Raposo, José María Segura Cabral, Cáncer de esófago, Medicina Clínica, 2008, 130, 11, 423

    CrossRef

  27. 27
    G. Créhange, P. Maingon, J.-F. Bosset, Chimioradiothérapie des cancers de l’œsophage : chronique d’un échec locorégional, Cancer/Radiothérapie, 2008, 12, 6-7, 640

    CrossRef

  28. 28
    E. Bollschweiler, R. Metzger, U. Drebber, S. Baldus, D. Vallbohmer, M. Kocher, A. H. Holscher, Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis, Annals of Oncology, 2008, 20, 2, 231

    CrossRef

  29. 29
    Feng-Ming Hsu, Chia-Chi Lin, Jang-Ming Lee, Yih-Leong Chang, Chih-Hung Hsu, Yu-Chieh Tsai, Yung-Chie Lee, Jason Chia-Hsien Cheng, Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study, Journal of Surgical Oncology, 2008, 98, 1
  30. 30
    Sarah K. Thompson, Andrew R. Ruszkiewicz, Glyn G. Jamieson, Adrian Esterman, David I. Watson, Bas P. L. Wijnhoven, Peter J. Lamb, Peter G. Devitt, Improving the Accuracy of TNM Staging in Esophageal Cancer: A Pathological Review of Resected Specimens, Annals of Surgical Oncology, 2008, 15, 12, 3447

    CrossRef

  31. 31
    G. Créhange, F. Bonnetain, B. Chauffert, P. Rat, L. Bedenne, P. Maingon, Prise en charge des adénocarcinomes de la jonction œsogastrique résécables : quel traitement périopératoire ?, Cancer/Radiothérapie, 2008, 12, 5, 365

    CrossRef

  32. 32
    Min Kyoung Kim, Sung- Bae Kim, Jin Hee Ahn, Yong Hee Kim, Jong Hoon Kim, Hwoon Yong Jung, Gin Hyug Lee, Kee Don Choi, Ho-Young Song, Ji Hoon Shin, Kyung-Ja Cho, Jin-Sook Ryu, Seung-Il Park, Treatment Outcome and Recursive Partitioning Analysis-Based Prognostic Factors in Patients With Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy, International Journal of Radiation Oncology*Biology*Physics, 2008, 71, 3, 725

    CrossRef

  33. 33
    Tomoki Makino, Yuichiro Doki, Hiroshi Miyata, Takushi Yasuda, Makoto Yamasaki, Yoshiyuki Fujiwara, Shuji Takiguchi, Ichiro Higuchi, Jun Hatazawa, Morito Monden, Use of 18F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma, Surgery, 2008, 144, 5, 793

    CrossRef

  34. 34
    J. Rüdiger Siewert, Katja Ott, Are Squamous and Adenocarcinomas of the Esophagus the Same Disease?, Seminars in Radiation Oncology, 2007, 17, 1, 38

    CrossRef

  35. 35
    Zhongxing Liao, James D. Cox, Ritsuko Komaki, Radiochemotherapy of Esophageal Cancer, Journal of Thoracic Oncology, 2007, 2, 6, 553

    CrossRef

  36. 36
    David Tougeron, Frédéric Di Fiore, Hadji Hamidou, Olivier Rigal, Bernard Paillot, Pierre Michel, Response to Definitive Chemoradiotherapy and Survival in Patients with an Oesophageal Adenocarcinoma versus Squamous Cell Carcinoma: A Matched-Pair Analysis, Oncology, 2007, 73, 5-6, 328

    CrossRef